News Agency
The Times

Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of First-in-class Antibody Drug HMI-115 Targeting Endometriosis and Androgenic Alopecia

  • Written by PR Newswire
  • Chime Biologics to support the late-stage clinical study and to provide global commercial manufacturing services for Hope Medicine's first-in-class monoclonal antibody drug, HMI-115.
  • The first-in-class mAb will benefit endometriosis and androgenetic alopecia patients.

SHANGHAI, Oct. 26, 2023 /PRNewswire/ -- Chime Biologics, a...

Read more: Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of...

Practical Ways to Help Reduce the Risk of Costly Business Disputes

Business disputes have a way of draining time, money and energy that could be better spent running your operation. While not every disagreement can be prevented, many disputes stem from issues that better planning may have reduced or avoided. Taking... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion